Human neuroblastoma: From basic science to clinical debut of cellular oncogenes

Naturwissenschaften

Volumn 86, Issue 2, 1999, Pages 71-78

  Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; GENE AMPLIFICATION; GERMANY; HUMAN; NEUROBLASTOMA; ONCOGENE; REVIEW;

CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; GENE AMPLIFICATION; GENE DELETION; GENES, MYC; HUMANS; NEUROBLASTOMA; ONCOGENES;

EID: 0033039024     PISSN: 00281042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001140050574     Document Type: Review

References (53)

1. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80:1707-1711
2. Amler LC, Schürmann J, Schwab M (1996) The DDXI gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma. Genes Chromosom Cancer 15:134-137
3. Amler LC, Schwab M (1989) Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Mol Cell Biol 9:4903-4913
4. Berthold F (1990) Overview: biology of neuroblastoma. In: Pochedly C (ed) Neuroblastoma: tumor biology and therapy. CRC, Boca Raton, pp 1-27
5. Berthold F (1994) Neuroblastom: Modelltumor und Herausforderung für den Kinderarzt. Monatsschr Kinderheilkd 142:296-310
6. Berthold F, Sahin K, Hero B, Christiansen H, Gehring M, Harms D, Horz S, Lampert F, Schwab M, Terpe J (1997) The current contribution of molecular factors to risk estimation in neuroblastoma patients. Eur J Cancer 33:2092-2097
7. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look T, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA (1993) Revisions of the international criteria for neuroblastoma diganosis, staging, and response to treatment. J Clin Oncol 11:1466-1477
8. Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Vo te PA, Versteeg R (1996) Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. N Engl J Med 334:225-230
9. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M (1997) Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplifications. Cell 89:215-225
10. Corvi R, Amler LC, Savelyeva L, Gehring M, Schwab M (1994) MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc Natl Acad Sci USA 91:5523-5527
11. Corvi R, Savelyeva L, Breit S, Wenzel A, Handgretinger R, Barak J, Oren M, Amler L, Schwab M (1995a) Non-systemic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene 10:1081-1086
12. Corvi R, Savelyeva L, Schwab M (1995b) Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 55:3471-3474
13. Debatisse M, Coquelle A, Toledo F, Buttin G (1998) Gene amplification mechanisms: the role of fragile sites. In: Schwab, M, Rabes H, Hofschneider P, Munk C (eds) Recent results in cancer research, vol. 154. Springer, Berlin Heidelberg New York, pp 216-228
14. Eklöf O, Sandstedt B, Thönell S, Ahström L (1983) Case report: spontaneous regression of stage IV neuroblastoma. Acta Paediatr Scand 72:473-476
15. Fiorillo A, Migliorati R, Tamburrini O, Pellegrini F, Vecchio P, Buffolano W, De Bernardi B (1982) Prolonged survival of a patient with disseminated neuroblastoma. J Pediatr 101:564-566
16. Fulda S, Lutz W, Schwab M, Debatin K-M (1999) MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene (in press)
17. Gaudray P, Szepetowski P, Escot C, Brinbaum D, Theillet C (1992) DNA amplification at 11q13 in human cancer: from complexity to perplexity. Mutat Res 276:317-328
18. Gehring M, Berthold F, Edler L, Schwab M, Amler LC (1995) The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res 55:5366-5369
19. Glover TW (1998) Instability at chromosomal fragile sites. In: Schwab, M, Rabes H, Hofschneider P, Munk C (eds) Recent results in cancer research, vol. 154. Springer, Berlin Heidelberg New York, pp 185-199
20. Guan X-Y, Meltzer PS, Dalton WS, Trent JM (1994) Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet 8:155-161
21. Hayashi Y, Kanda N, Inaba T, Hanada R, Naghara N, Muchi H, Yamamoto K (1989) Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126-132
22. Ibson JM, Rabbits PH (1988) Sequence of a germ-line N-myc gene and amplification as a mechanism of activation. Oncogene 2:399-402
23. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT (1993) Coamplification of the CDK4 gene with MDM 2 and GLI in human sarcomas. Cancer Res 53:5535-5541
24. Kushner BH, Gilbert F, Helson L (1986) Familial neuroblastoma. Case reports, literature review, and etiologic considerations. Cancer 57:1887-1893
25. Lutz W, Fulda S, Jeremias I, Debatin K-M, Schwab M (1998) MycN and IFNg cooperate in apoptosis of human neuroblastoma cells. Oncogene 17:339-346
26. Lutz W, Schwab M (1997) In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells. Oncogene 15:303-315
27. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM (1995) Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 55:4664-4669
28. Nishi M, Miyake H, Takeda T, Shimada M, Takasugi N, Sato Y, Hanai J (1987) Effects of the mass screening of neuroblastoma in Sapporo City. Cancer 60:433-436
29. Praml C, Finke LH, Herfarth C, Schlag P, Schwab M, Amler L (1995) Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11:1357-1352
30. 1-Aldehyde Reductase Gene at 1p35-1p36.1 in a Region Frequently Altered in Human Tumor Cells. Cancer Res 58:5014-5018
31. Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Benard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemmerle J, Sommelet D (1997) N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 15:1171-1182
32. Savelyeva L, Corvi R, Schwab M (1994) Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340
33. Sawada T, Kodowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T (1984) Neuroblastoma, mass screening for early detection and its prognosis. Cancer 53:2731-2735
34. Schimke RT (1984) Gene amplification in cultured animal cells. Cell 37:705-713
35. Schimke RT (1992) Gene amplification; what are we learning? Mutat Res 276:145-149
36. Schwab M, Alitalo K, Varmus HE, Bishop JM, George D (1983a) A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature 303:497-501
37. Schwab M, Alitalo K, Klempnauer K-H, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983b) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245-248
38. Schwab M, Varmus HE, Bishop JM, Grzeschik K-H, Naylor SL, Sakaguchi AY, Brodeur G, Trent J (1984a) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308:288-291
39. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, Bisohop JM (1984b) Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 81:4940-4944
40. Schwab M, Varmus HE, Bishop JM (1985a) Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316:160-162
41. Schwab M, Ramsay G, Alitalo K, Varmus HE, Bishop JM, Martinsson T, Levan G, Levan A (1985b) Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumor cells. Nature 315:345-347
42. Schwab M, Bishop JM (1988) Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence. Proc Natl Acad Sci USA 85:9585-9589
43. Schwab M, Amler LC (1990) Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1:181-193
44. Schwab M, Corvi R, Amler LC (1995) N-MYC oncogene amplification: a consequence of genomic instability in human neuroblastoma. Neuroscientist 1:277-285
45. Schwab M, Praml C, Amler LC (1996) Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 16:211-229
46. Schwab M, Joshi V (1997) Neuroblastic tumours of the adrenal gland and sympathetic nervous system. In: Kleihues P, Cavenee WK (eds) Pathology and genetics. Tumours of the nervous system. International Agency for Cancer Research, Lyon pp 117-123
47. Schwab M (1998) Amplification of oncogenes in human cancer cells. Bioessays 20:473-479
48. Spradling AC, Mahowald AP (1980) Amplification of genes for chorion proteins during oncogenesis in Drosophila melanogaster. Proc Natl Acad Sci USA 77:1096-1100
49. Srivatsan ES, Ying KL, Seeger RC (1993) Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosomes Cancer 7:32-37
50. Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J (1995) Allelotype of neuroblastoma. Oncogene 11:1829-1834
51. Versteeg R, Caron H, Cheng NC, van der Drift P, Slater R, Westerveld A, Vo te PA, Delattre O, Laureys G, Van Roy N, Speleman F (1995) 1p36:Every subband a suppressor?Europ J Cancer 31A:538-541
52. Wenzel A, Cziepluch C, Hamann U, Schürmann J, Schwab M (1991) The N-myc oncoprotein is associated in vivo with the phosphoprotein Max (p20/22) in human neuroblastoma cells. EMBO J 10:3703-3712 (1991)
53. Wenzel A, Schwab M (1995) The MYCN/MAX protein complex in neuroblastoma: short Review. Eur J Cancer 31:516-519